Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Biologically plausible and evidence-based risk intervals in immunization safety research.
Natural, innate improvements in multiple sclerosis disability.
Inhibition of Calcineurin Abrogates While Inhibition of mTOR Promotes Regulatory T Cell Expansion and Graft-Versus-Host Disease Protection by IL-2 in Allogeneic Bone Marrow Transplantation.
[Epidemiology and clinical assessment of spasticity in multiple sclerosis].
Active intrathecal herpes simplex virus type 1 (HSV-1) and human herpesvirus-6 (HHV-6) infection at onset of multiple sclerosis.
Acute hypercalcemia following excessive calcium supplementation in a dehydrated patient with progressive multiple sclerosis: vitamin d supplementation is a red herring-reply.
A cluster randomised controlled trial on the efficacy of client-centred occupational therapy in multiple sclerosis: good process, poor outcome.
Immune-related GTPase Irgm1 exacerbates experimental auto-immune encephalomyelitis by promoting the disruption of blood-brain barrier and blood-cerebrospinal fluid barrier.
Inflammatory events at blood-brain barrier in neuroinflammatory and neurodegenerative disorders: implications for clinical disease.
[Case report: a case of chronic inflammatory demyelinating polyneuropathy (CIDP) exacerbated by influenza vaccination].
Gammaherpesvirus Infection of Human Neuronal Cells.
Impact of Repeated Topical-Loaded Manganese-Enhanced MRI on the Mouse Visual System.
The recurrent Guillain-Barré syndrome: a long-term population-based study.
Effect of Riluzole as a Symptomatic Approach in Patients With Chronic Cerebellar Ataxia
Asymptomatic Progressive Multifocal Leukoencephalopathy Associated with Natalizumab: Diagnostic Precision with MR Imaging.
Cerebellar-parietal dysfunctions in multiple sclerosis patients with cerebellar signs.
Ultra-high-field imaging distinguishes MS lesions from asymptomatic white matter lesions.
The risk of fracture in incident multiple sclerosis patients: The Danish National Health Registers.
Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial.
[Symptoms of circadian desynchronization in patients with multiple sclerosis.]
Aging, widowhood, multiple sclerosis, and a dog.
Preserved vascular integrity and enhanced survival following neuropilin-1 inhibition in a mouse model of CD8 T cell-initiated CNS vascular permeability.
The nervous system's potential role in multiple sclerosis associated bone loss.
A Web-based tool for personalized prediction of long-term disease course in patients with multiple sclerosis.
Genetic characterization of gliomas arising in patients with multiple sclerosis.
Pages
« first
‹ previous
…
173
174
175
176
177
178
179
180
181
…
next ›
last »